Numerai GP LLC: UEC position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Numerai GP LLC on UEC, newest first. How the timeline and the estimate are built.
Numerai GP LLC held 76,444 UEC shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 76,444 sharesChange vs previous 13F -61,363 shares
0.07% of the 13F portfolio, value $814,893.
13F-HR 0001214659-26-010378 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 137,807 sharesChange vs previous 13F +126,005 shares
0.19% of the 13F portfolio, value $1,860,394.
13F-HR 0001214659-26-006464 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 11,802 sharesChange vs previous 13F +11,802 shares
0.02% of the 13F portfolio, value $137,847.
13F-HR 0001214659-26-001975 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -14,257 shares
13F-HR 0001214659-25-007830 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 14,257 sharesChange vs previous 13F -103,046 shares
0.03% of the 13F portfolio, value $95,379.
13F-HR 0001214659-25-002840 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 117,303 sharesChange vs previous 13F not available
0.19% of the 13F portfolio, value $728,452.
13F-HR 0001214659-24-019138 filed by Numerai GP LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).